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Background: Lentiviral vectors have emerged as efficient vehicles for transgene delivery in both dividing and
non-dividing cells. A number of different modifications in vector design have increased biosafety and transgene
expression. However, despite these advances, the transduction of primary human T cells is still challenging and
methods to achieve efficient gene transfer are often expensive and time-consuming.
Results: Here we present a simple optimised protocol for the generation and transduction of lentivirus in primary
human CD45RA+ T cells. We show that generation of high-titre lentivirus with improved primary T cell transduction is
dependent upon optimised ultracentrifuge speed during viral concentration. Moreover, we demonstrate that transduction
efficiency can be increased with simple modifications to the culturing conditions. Overall, a transduction efficiency of up
to 89% in primary human CD45RA+ cells is achievable when these modifications are used in conjunction.
Conclusion: The optimised protocol described here is easy to implement and should facilitate the production
of high-titre lentivirus with superior transduction efficiency in primary human T cells without the need for further
purification methods.
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Replication-deficient pseudotyped lentiviral vectors are
widely used as basic tools in research and have the potential
to be utilised as therapeutic agents in severe immunodefi-
ciencies [1,2]. Production of HIV-derived lentiviral vectors
is performed by transfecting vectors harbouring self-inacti-
vating long terminal repeat (LTR) regions together with
the transgene on one vector (the transfer vector), while
the additional transcripts required for packaging (Gag/Pro/
Pol) and encapsulation (Env) are encoded on separate
vectors [3]. In second-generation packaging systems,
all packaging genes are encoded by one vector that is
transfected along with the transfer vector and encapsula-
tion vector to generate virions. In the third-generation
packaging system the Rev gene is encoded on a separate
packaging plasmid, leading to increased biosafety [4].* Correspondence: adam.cribbs@kennedy.ox.ac.uk
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stated.Concentration of lentiviral stocks is performed to in-
crease lentivirus titre and remove impurities for superior
transduction of target cells. Typically ultracentrifugation
is used, although other techniques such as ultrafiltration
[5-7] and ultracentrifugation over a density gradient [7,8]
are also commonly used. Numerous studies have devel-
oped optimised lentiviral production protocols based on
these procedures [6,9,10], however most approaches
have focused their attention on obtaining high lentivirus
titre, with little regard given to the infectivity of virus
produced.
Efficient lentiviral transduction of numerous cell lines
has been demonstrated previously [11]. In contrast, primary
human T cells are refractory to transduction by lentivirus,
with quiescent T cells being particularly problematic to
transduce [12,13]. Furthermore, the completion of reverse
transcription and integration into the genome does not
occur unless T cells are activated through the TCR and/or
by proliferative cytokines [14].
In this study we have generated high-titre lentivirus
with superior transduction efficiency in primary humanLtd. This is an Open Access article distributed under the terms of the Creative
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iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
Cribbs et al. BMC Biotechnology 2013, 13:98 Page 2 of 8
http://www.biomedcentral.com/1472-6750/13/98T cells. Specifically, we demonstrate that time consuming
and costly additional purification methods are dispensable
when lentivirus is concentrated using lower centrifuge
speeds. This resulted in both increased lentiviral titres and
increased infectivity in human primary T cells. Moreover,
we show that transduction efficiency can be improved




HEK 293T/17 cells (ATCC No. CRL-11268) were cultured
in high glucose-containing Dulbecco’s modified Eagle’s
medium (DMEM; Lonza) supplemented with 10% foetal
calf serum (FCS, Gibco) at 37°C at 5% CO2, unless other-
wise stated. Human T lymphocyte derived Jurkat cells
(ATCC No. TIB-152) were cultured in RPMI 1640 (Lonza)
supplemented with 5% FCS prior to transduction.
Primary CD45RA T cell isolation and stimulation
Human peripheral blood mononuclear cells (PBMCs) were
isolated from electrophoresis cones (North London Blood
Transfusion Service) or healthy volunteers by Ficoll-Hypa-
que centrifugation. Human blood collections were taken
following written informed consent and approval of the
London Riverside research committee, REC number: 07/
H0706/81 and in agreement with the Helsinki Declaration.
Peripheral blood lymphocytes (PBLs) were isolated by
centrifugal elutriation. CD4+CD45RA+ cells were isolated
from PBLs by negative bead isolation (Miltenyi). Lympho-
cytes were stimulated with either plate bound anti-CD3
(OKT3 – Insight Biotechnology) and soluble anti-CD28
(BD Pharmingen) or anti-CD3/CD28 activation beads
(Invitrogen). Cells were cultured in X-VIVO 15 (Lonza)
and supplemented with either 5% FCS or 5% Human
serum (Biosera), together with IL-2 (100 ng/mL) and IL-7
(15 ng/mL).
Plasmid constructs
The pCCL-Empty plasmid was constructed from a previ-
ously characterised vector, MA1, in which two transgenes
can be efficiently transcribed from a bi-directional origin:
with the minimal cytomegalovirus promoter for ΔNGFR
(a truncated form of the nerve growth factor receptor),
and a second transgene transcribed from the human
phosphoglycerate kinase promoter [15]. The pCCL-Empty
plasmid was kindly provided by Prof M Levings [16].
The lentivirus packaging plasmids, psPAX2, pRSV-Rev,
pMDLg/pRRE and the pMD2. G envelope plasmid con-
taining VSV-G were kindly provided by D. Trono [4]. For
lentivirus production, plasmids were prepared using the
Endofree Plasmid Maxi kit (Qiagen) according to manu-
facturer’s protocol.Preparation of flasks for lentivirus production
Lentiviral vectors expressing the ΔNGFR gene were pro-
duced as follows. 24 hrs prior to transfection, 25 × 106
293T cells were plated onto poly-L-lysine (Sigma) coated
175 cm2 flasks. Two hrs prior to transfection, medium
was replaced with RPMI 1640 supplemented with 5% FCS.
All solutions were sterilised by filtration through 0.22 μm
filters. Solutions were stored in aliquots at -20°C, and
thawed prior to use.
Standard lentivirus production and concentration
procedure
The lentiviral transfer vector DNA, together with psPAX2
packaging and pMD2. G envelope plasmid DNA were
combined at a ratio of 4:3:1, respectively. Production of 3rd
generation lentivirus was performed using the combined
ratio of transfer plasmid, packaging plasmid, Env plasmid
and pRSV-Rev plasmid at 4:2:1:1, respectively. The precipi-
tate was formed by adding 80 μg of DNA to a final volume
of 1.35 mL distilled H2O and 150 μl 2.5M CaCl2 (Sigma).
A sterile 2 mL pipette was used to vigorously bubble air
through the DNA mix, during which, 1.5 mL 2× HEPES-
buffered saline (280 mM NaCl, 50mM HEPES, 1.5 mM
Na2HPO4, pH 7.0) was added dropwise into the precipi-
tate. The solution was briefly vortexed and incubated at
room temperature for 30 min. Following this, the solution
was mixed again by gentle vortexing, and then added
dropwise to the cells. Flasks were rocked gently in a circular
motion to distribute the precipitates, and then returned to
the incubator at 3% CO2 unless otherwise stated. Four to
six hrs later, cells were gently washed once with PBS and
fresh growth medium added. Sixteen hrs post-transfection,
the medium was replaced with RPMI supplemented with
5% FCS unless otherwise stated and incubated at 5% CO2
for 24 hrs prior to the initial collection of viral supernatant.
A second collection was made after a further 24 hrs. The
conditioned medium from the two harvests was combined
and cleared by centrifugation at 1500 rpm for 5 min at 4°C
then passed through a 0.45 μm pore PVDF Millex-HV filter
(Millipore).
Concentration of lentivirus using ultracentrifugation was
performed with a Sorval Discovery 100 SE centrifuge using
an AH-629 rotor. 30 mL of filtered lentivirus supernatant
was added to 36 mL pollyallomer conical tubes (Beckman).
Centrifugation was performed for 90 min at 90,000 g unless
otherwise stated. Supernatant was completely removed and
virus pellets resuspended in 300 μL PBS overnight at 4°C
and stored at -80°C until use.
Lentiviral transduction of primary T cells
Lentivirus was added to primary CD45RA+ lymphocytes
cultured in X-VIVO media supplemented with 10% FCS
(initial culturing conditions) or 10% HS (final optimal
culturing conditions) and 6 μg/mL polybrene. Lentivirus
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of 50. After overnight incubation, lentivirus was removed
and fresh media added. Following 48 hrs (initial culturing
conditions) or 24 hrs (final optimal culturing conditions)
of culture the cells were removed and NGFR+ cells were
determined by flow cytometry using antibody APC-CD271
(BD Pharmingen).
Lipofectamine transfection
Where lipofectamine (Invitrogen) reagents were used for
comparison of transfection methods, 80 μg plasmid DNA
was again used in the same ratio as with the calcium phos-
phate method and transfections were carried out according
to the manufacturer’s protocol.
Acrodisc purification
Purification of lentivirus using a Mustang Q Acrodisc
(PALL) was performed according to the manufacturer’s
recommendations. Briefly, 50 mL aliquots of lentivirus
supernatant were adjusted to 25 mM Tris-HCl, pH 8.9 and
loaded onto a Mustang Q Acrodisc and filtered through
the Acrodisc syringe filter. The Acrodisc was eluted using
a step gradient ranging from 0.3 to 1.5 M NaCl in 25 mM
Tris-HCl, pH 8.5. Filtered supernatant was then added to
36 mL pollyallomer conical tubes and ultracentrifuged at
20,000 g for 90 min.
Optiprep purification
For concentration using Optiprep (Axis-shield), a 220 μL
cushion of Optiprep was added to pollyallomer conical
tubes and lentivirus-containing supernatant (30 mL) was
gently layered into each tube taking care not to disturb
the Optiprep. Samples were ultracentrifuged at 20,000 g
for 90 min. Media above the media/Optiprep interface
was carefully removed from each tube and discarded. The
residual media containing lentivirus and Opitiprep was
shaken at 200 rpm for 2 hrs in sealed tubes. The resulting
mixture was pooled and centrifuged at 20,000 g for 24 hrs.
Supernatant was discarded and the remaining pellet was
resuspended in 300 μL of PBS, shaken overnight at 4°C,
and then stored at -80°C until use.
Titration
Titres were determined by transducing 1 × 105 Jurkat cells
in 100 μl of RPMI 1640 growth medium. Titres were
determined in triplicate with serial dilutions from 1:10
to 1:1000 for un-concentrated vector stocks, or from 1:100
to 1:10000 for concentrated vector stocks in a final volume
of 100 μl with 6 μg/mL polybrene (Sigma). The following
day, plates were spun at 1,500 rpm for 5 min to remove
cells from suspension and fresh growth medium added.
After a further 48 hr incubation, cells were harvested and
NGFR expression was determined by flow cytometry
using APC-CD271 antibody (BD Pharmingen). Titres weredetermined based on the percentage of NGFR positive cells
and calculated according to the following formula (F × N ×
D × 1,000)/V, where F = percentage cells positive for
NGFR, N = number of cells at time of transduction (usually
1 × 105 cells), D = fold dilution of vector used in transduc-
tion, V = volume (μl) of diluted vector sample in each
well. The virus titre is expressed as transducing units/mL
(TU/mL) ± standard error [5].
Final simplified production and concentration
of lentivirus
25 × 106 293T cells were plated onto poly-L-lysine (Sigma)
coated 175 cm2 flasks. Two hrs prior to transfection,
medium was replaced with RPMI 1640 supplemented with
5% FCS.
The lentiviral transfer vector DNA, together with pack-
aging and envelope plasmid DNA were combined at a
ratio of 4:1:3 respectively. The precipitate was formed
by adding 80 μg of DNA to a final volume of 1.35 mL
distilled H2O and 150 μl 2.5M CaCl2 (Sigma). A sterile
2 mL pipette was used to bubble air through the DNA mix,
during which, 1.5 mL 2x HEPES-buffered saline (280 mM
NaCl, 50 mM HEPES, 1.5 mM Na2HPO4, pH 7.0) was
added dropwise into the precipitate. The solution was
briefly vortexed and incubated at room temperature for
30 min. Following this, the solution was mixed again by
gentle vortexing, and then added dropwise to the cells.
Flasks were rocked gently in a circular motion to distrib-
ute the precipitates, and then returned to the incubator at
3% CO2 unless otherwise stated. Four to six hrs later, cells
were gently washed once with PBS and fresh growth
medium added. Sixteen hrs post-transfection, the medium
was replaced with RPMI supplemented with 5% FCS un-
less otherwise stated and incubated at 5% CO2 for 24 hrs
prior to the initial collection. Sodium butyrate (Sigma)
was added 16 hr post-transfection into the culture medium
at a final concentration of 1mM. A second collection was
made after a further 24 hrs. The conditioned medium from
the two harvests was combined and cleared by centrifuga-
tion at 1500 rpm for 5 min at 4°C then passed through a
0.45 μm pore PVDF Millex-HV filter (Millipore).
Concentration of lentivirus using ultracentrifugation
was performed with a Sorval Discovery 100 SE centrifuge
using an AH-629 rotor. 30 mL of filtered virus supernatant
was added to 36 mL pollyallomer conical tubes (Beckman).
Centrifugation was performed for 90 min at 20,000 g.
Supernatant was completely removed and virus pellets
resuspended in 300 μL PBS overnight at 4°C and stored
at -80°C until use.
Statistical analysis
We used Graph Pad Prism 6 for analysis. We used one-way
analysis of variance with Bonferroni correction and Stu-
dent’s t test to determine differences between groups.
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ered statistically significant.Results and discussion
Comparison of lipofectamine and calcium phosphate
transfection to generate lentivirus
In an initial set of experiments, the transfection efficiency
of lipofectamine and a less expensive calcium phosphate
based method, were compared. Calcium phosphate or
lipofectamine transfection of HEK 293T cells was carried
out in the presence or absence of 1mM sodium butyrate,
which has previously been shown to function as an en-
hancer of mammalian cell transfection efficiency [17].
As shown in Figure 1A, in the absence of sodium butyrate,
the titres of lentivirus produced using lipofectamine-medi-
ated transfection were significantly higher than those pro-
duced by the calcium phosphate based method. Addition
of sodium butyrate resulted in a moderate improvement
on virus titres produced by lipofectamine transfection.
In contrast, a significant increase was observed in titres
following sodium butyrate treatment of cells transfected
by the calcium phosphate method. In fact, this resulted in
titres comparable to those observed using the lipofectamine
based method. Therefore all further transfections were
carried out using the calcium phosphate and sodium
butyrate transfection method.
In the previous experiments, use of sodium butyrate
enhanced the titres of lentiviral vectors in all cases [18].
To determine the optimal concentration of sodium butyr-
ate in the culture medium with the calcium phosphate
transfection, lentiviral vector titres produced from cellsFigure 1 High titre virus generated in 293T cells using calcium
phosphate and sodium butyrate. A. 293T cells were transfected
with pCCL, psPAX2 and pMD2. G packaging plasmids using
lipofectamine in the presence or absence of sodium butyrate, or
calcium phosphate in the presence or absence of sodium butyrate.
Data shown represents mean ± s.d. of six independent transfections
B. Calcium phosphate transfection in 293T cells was performed
using decreasing concentrations of sodium butyrate. Data represent
mean ± s.d. of three independent experiments. *P < 0.05, **P < 0.01,
***P < 0.001 using one-way ANOVA with Bonferroni comparison.cultured in medium containing a range of sodium butyrate
concentrations were determined. As shown in Figure 1B,
compared to non-supplemented transfections, the use
of sodium butyrate increased virus titres when present at
concentrations of 10 mM down to 1 μM in the culture
medium. The highest viral titres were achieved using
sodium butyrate at a concentration of 1 mM, with the
presence of sodium butyrate at this concentration resulting
in a ~6-fold increase in lentiviral titres compared to no so-
dium butyrate. Therefore for all further experiments 1mM
sodium butyrate was added at 16 hr post-transfection.
Comparison of the second and third lentivirus
packaging systems
With the second-generation lentivirus packaging system,
the Gag/Pro/Pol and Rev genes are encoded on a single
plasmid and this was used, in addition to the transfer
plasmid and envelope plasmid to produce lentivirus. In
contrast, in the third-generation lentivirus packaging
system, the Rev gene is encoded on a separate plasmid to
the Gag/Pro/Pol genes, thereby necessitating the co-trans-
fection of four plasmids as opposed to three for virus
production [4]. As shown in Figure 2A, the second gener-
ation lentivirus vectors produced approximately fifty times
more total yield of virus than the third generation. The
ability to transduce difficult to infect cells such as primary
T cells is dependent upon the ability to produce high viral
yields with a sufficiently high titre [19]. Therefore we
investigated the transduction efficiency of the second and
third generation lentivirus systems in primary human
CD45RA+ T cells. Following titration, equivalent MOIs
were calculated for the second and third generation
systems and used to transduce primary T cells. This re-
vealed that the third-generation system did not have
any beneficial effect on the ability of the viral vector to
transduce these cells (Figure 2B). Therefore, due to theFigure 2 Concentration of a second generation packaging system
generates virus with superior transduction efficiency in primary
CD45RA+ T cells. A. The total transducing units generated using second
and third generation packaging systems. B. The level of transduction for
the second and third generation packaging systems in CD45RA+ T cells
as measured by flow cytometry. Data represents mean ± s.d. of three
independent preparations. ***P < 0.001 using Students t-test.
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generation system, this system was used for the generation
of all subsequent viral vector preparations.
Comparison of lentivirus titre/transduction efficiency
following ultracentrifugation and purification using
Optiprep and Acrodisc
It is commonplace to concentrate lentivirus by ultracentri-
fugation to obtain sufficient viral titres to transduce cells at
a high MOI and remove contaminating impurities for
sensitive in vivo applications. The standard procedure
for concentrating lentivirus involves ultracentrifugation at
90,000 g for 90 min [20,21]. In order to use higher titres of
lentivirus in our experiments we compared unconcentrated
lentivirus with lentivirus concentrated by ultracentrifuga-
tion at 90,000 g for 90 min. We found that concentrating
lentivirus resulted in a 10-fold reduction in virus yield,
suggesting that significant amounts of virus are lost or
lose infectivity during ultracentrifugation (Figure 3A).
However, we showed a significant increase in the NGFR
expression when primary CD45RA+ T cells are transduced
at equivalent transducing units with the concentrated
lentivirus (Figure 3B). This suggests that concentration
removes impurities in the virus supernatant, which can
enhance the transduction efficiency.
Concentrating lentivirus with reduced centrifuge speeds
has previously been shown to increase the titre of lentivirus
[22]; however whether this equates to increased transduc-
tion efficiency in primary T cells has never been demon-
strated. Concentration of lentivirus is usually performed at
90,000 g [5,23], although some have shown that recovery
of virus increases if the virus is centrifuged at a reduced
speed of 20,000 g [9]. Similarly we showed a significant
increase in virus titre (Figure 3C) and virus recovery
(Additional file 1: Figure S1), which correlated with a
significant increase in transduction in CD45RA+ T cells
when virus was spun at 20,000 g (Figure 3D), suggesting
that reduced spin speed improves virion stability and
infectivity. Reduction of spin speed to 6,400 g resulted in a
substantially reduced lentivirus titre and did not improve
transduction of CD45RA+ T cells. These results suggest
that optimisation of centrifugation speed is important
to generate the highest titre of lentivirus with optimal
infectivity and that high spin speeds may reduce virus
recovery and lower transduction efficiency in primary
human CD45RA+ T cells.
Having determined that concentrating virus at a lower
speed results in improved lentivirus titres and transduction
efficiency, we next determined whether we could improve
lentivirus infectivity further by density gradient concen-
tration (Optiprep) or ultrafiltration (Mustang Q Acrodisc).
However, we found that using either Optiprep or Acro-
disc concentration techniques resulted in a reduction in
overall lentivirus titre (Figure 3E) and virus recovery(Additional file 1: Figure S2), which correlated with reduced
transduction of primary CD45RA+ T cells (Figure 3F).
These results suggest that centrifuging lentivirus at lower
speeds negates the use of more costly and time-consuming
purification techniques and is sufficient to remove impur-
ities that may otherwise reduce transduction efficiency.Achieving high transduction of primary naïve T cells
through modification of culturing conditions
Having optimised lentivirus production and concentration
we next determined optimum culture conditions for trans-
ducing primary CD45RA+ T cells. For this optimisation we
used lentivirus that had been produced using the ‘standard’
lentivirus production/concentration protocol as listed in
the material and methods. Primary cells are notoriously
difficult to transduce with lentivirus, although it has
been shown that inducing cell-cycle entry into G1b via
stimulation of the T cell receptor allows increased trans-
duction of naïve T cells [14,24]. This suggests that the
strength of TCR signalling may be important for increased
transduction efficiency. Therefore, we began to modify a
standard protocol used to transduce primary T cells [16]
(see material and methods for protocol). We determined
whether stimulating CD45RA+ T cells with either plate
bound anti-CD3 (5 μg/mL) and soluble anti-CD28
(1 μg/mL) or anti-CD3/CD28 activation beads (used at a
1:5 bead: cell ratio) led to increased transduction efficiency.
We demonstrate that activating primary cells with anti-
CD3/CD28 activation beads resulted in 1.94 fold increase
in transduction efficiency (Figure 4A). Interestingly, this
increase in transduction was associated with increased
expression of activation markers CD25 and CD45RO+
(data not shown), suggesting that the cells were more
activated. Our next step in optimisation was to determine
whether the use of HS increased transduction efficiency.
When human serum was used as a growth supplement, a
significant increase in transduction was observed when
compared to FCS cultured cells (Figure 4B), a modification
that also led to increased activation marker expression (data
not shown). One explanation for increased transduction
efficiency could be that more cells are cycling, making
them more amenable to transduction.
Having shown that transduction efficiency can be im-
proved by using CD3/28 activation beads in combination
with HS, we next determined transduction efficiency in
unstimulated T cells and following 0, 24 and 48 hrs of TCR
stimulation. There were no significant changes in the num-
bers of NGFR expressing cells between CD45RA+ cells
that were transduced unstimulated or following stimulation
with activation beads for 0, 24 or 48 hrs (Figure 4C). How-
ever a significant increase in the MFI of ΔNGFR was seen
following transduction after 24 hrs of TCR stimulation
(Figure 4D), suggesting that the cell cycle stage at which
Figure 3 Ultracentrifugation at 20 000 g improves virus titre and transduction efficiency in primary CD45RA+ T cells. A. Virus titre
measured before and after concentration by ultracentrifugation. B. The level of transduction using un-concentrated and concentrated lentivirus
supernatant as measured by flow cytometry. C. Virus titre measured following centrifugation of viral supernatants at decreasing centrifugal
speeds. D. Assessment by flow cytometry of transduction by lentivirus following concentration with decreasing centrifugal speeds. E. Virus titre
measured following concentration of lentivirus using ultracentrifugation, Optiprep and Acrodisc methods. F. The level of transduction of each of
the concentrated lentivirus stocks as measured by flow cytometry. *P > 0.05, **P > 0.01, ***P > 0.001 as determined by one-way ANOVA with
Bonferroni correction or Students t-test. Data is represented as mean ± s.d. of three independent experiments and virus preparations.
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transgene expression, which is likely due to increased
number of transgene integrations per cell.
High transduction efficiency in primary T cells
Having optimised culturing conditions using lentivirus pro-
duced using the ‘standard’ protocol, we next determined
the effect of combining the ‘final’ lentivirus generationprotocol with the modified culture conditions. When these
combinations were made and primary T cells were trans-
duced with three independent lentivirus preparations we
found that we could achieve high transduction efficiency,
as measured by ΔNGFR expression (combined ΔNGFR
expression 79.81 ± 14.68%) (Figure 5A), demonstrating the
importance of fully optimised lentiviral production and
transduction techniques.
Figure 4 Optimal culturing conditions for highly efficient transduction of primary CD45RA+ T cells. A. Virus was generated using the
standard production and concentration protocol. Primary CD45RA+ T cells were stimulated using plate bound anti-CD3 (5 μg/mL) and soluble
anti-CD28 (1 μg/mL) or with CD3/CD28 activation beads (1 bead to 5 cells) then transduced following 24 hrs of stimulation. ***P < 0.001 as
determined by Students t-test. Data represent mean ± s.d. of three independent experiments. B. Primary CD45RA+ T cells were stimulated with
CD3/CD28 activation beads for 24 hrs then transduced and cultured in X-VIVO media supplemented with 10% FCS or 10% HS. ***P < 0.001 as
determined by students t-test. Data represent mean ± s.d. of three independent experiments. C and D. Primary CD45RA+ T cells were stimulated
using CD3/CD28 activation beads and cultured in X-VIVO media supplemented with 10% HS and transduced following 0, 24 and 48 hrs of activation.
*P < 0.05 as determined by one-way ANOVA with Bonferroni correction. Data represent mean ± s.d. of three independent experiments.
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Lentiviral transduction of exogenous genes into primary
cells is technically challenging, requiring the preparation
of high titre viral stocks and optimal culture conditions.
The generation of lentivirus requires the transfection of a
stable producer cell line, such as 293Tcells. We have shown
that transfection of 293T cells with a second-generation
lentivirus system produces virus with sufficiently high
titre to transduce primary T cells, compared to the third-
generation system. While this approach increased viral
titre, the viral supernatants did not generate sufficiently
high transduction efficiency. To increase the virus trans-
duction efficiency we sought to concentrate the virus
supernatant, thereby allowing for the use of a high MOI
whilst at the same time reducing contaminating material
in the supernatant. We determined that it was possible
to increase virus transduction efficiency by concentrationFigure 5 High transduction of lentivirus in primary human T cells. Prim
lentivirus generation and concentration protocol in combination with mod
representative histogram from one donor of NGFR expression following tra
expression from three lentivirus preparations in nine independent experim
using flow cytometry to determine the percentage of NGFR expression.using ultracentrifugation. Transduction efficacy could be
improved further by reducing the centrifugal speed from
the standard protocol (90,000 g) to 20,000 g. In contrast,
Acrodisc and Optiprep concentration and purification
techniques gave little improvement over ultracentrifugation,
and actually led to reduced viral titres and transduction of
primary CD45RA+ T cells, potentially due to an increase in
damaged virion particles. In addition to virus generation we
also showed that transduction efficiency can be improved
by modifications to cell culture conditions, specifically we
showed that the strength of TCR stimulation and the time
of transduction following stimulation affects transduction
efficiency. Interestingly, we also showed that lentivirus
can transduce unstimulated T cells to similar efficiency
to stimulated primary T cells; however the expression of
the transgene is low. Overall, we demonstrate an easy and
robust protocol to generate and transduce lentivirus atary CD45RA+ T cells were transduced using the ‘final’ simplified
ifications made to the culturing conditions. Left panel shows
nsduction with lentivirus. Right panel shows the percentage NGFR
ents. Transduction efficiency was determined 24 hrs post-transduction
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simple to achieve and does not require additional expensive
laboratory equipment.
Additional file
Additional file 1: Figure S1. Ultracentrifugation at 20 000 g improves
the overall virus recovery. Virus recovery was measured before and after
centifugation of lentivirus at decreasing centrifugal speeds. Virus recovery
was then expressed as a percent of the total TU of starting
unconcentrated lentivirus. *P > 0.05, **P > 0.01 as determined by Students
t-test. Data is represented as mean ± s.d. of three independent experi-
ments. Figure S2. Virus recovery is reduced following purification using
Optiprep and Acrodisc. Virus recovery was measured before and after
ultracentrifugation, Optiprep and Acrodic methods. Virus recovery was
then expressed as a percent of the total TU of starting unconcentrated
lentivirus. *P > 0.05, **P > 0.01 as determined by Students t-test. Data is
represented as mean ± s.d. of three independent experiments.
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